Government Funding of CRISPR Research and Policy Changes
Federal CRISPR research funding continues to rise
Tanya Samazan has written about the analytical and life science instrument industry for over 15 years. She has conducted hundreds of in-depth interviews with industry leaders and participants for IBO. She has written extensively about major companies, business trends, end-markets and technology developments, providing insight and analysis about industry prospects and developments. Her comments have also appeared in Chemical & Engineering News. Tanya is a graduate of UCLA and previously worked at the UCLA Law Review.
Federal CRISPR research funding continues to rise
Tapestri system facilitates analysis into disease biology and treatment outcomes
Hungary 2017 R&D spending grows over 20%
Life Sciences leads the pack in academic R&D spending
Illumina, IDT, Fluidigm among winners at 2018 LSIAs
Nonmetallic metals lead 2017 materials usage
Scientists cite improved support from instrument manufacturers, updates to instrumentation as key needs
Bio-Techne looks to $1.2 billion in revenues in FY23
Countries around the world invest in dementia R&D
German chemical revenues rise, as number of R&D employees declines
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
